Clearsight Advises Penn Quarter Partners on an Investment by Webster Equity Partners

Clearsight Advisors, Inc. (Clearsight) announced that Webster Equity Partners (Webster) has made a strategic investment in Penn Quarter Partners (PQP) to accelerate the growth of a highly specialized consulting platform for life sciences companies navigating complex regulatory, policy, and market challenges.

The life sciences sector today faces mounting pressures—from policy shifts and reimbursement and access hurdles, to reputational risk and rapid innovation. For over 13 years, PQP has guided companies at the forefront of medical advancements with strategic planning, research and analytics, campaign and issues management, and integrated communications. The firm’s success is built on deep, long-standing client relationships and a seasoned team with expertise across the diagnostic, device, and biopharmaceutical sector—from startups to multinational manufacturers.

The investment also supports the continued growth of Context Strategies, enhancing PQP’s ability to deliver fully integrated campaigns that drive meaningful outcomes for clients.

“Healthcare innovators today need more than just advice—they need partners who understand the environment, as well as how to shape perception and deliver results,” said Wes Metheny, Founding Partner of PQP. “We’ve built a platform that brings data-driven communications and advocacy together to create enduring client partnerships. With Webster’s support, we’ll deepen our capabilities, expand our reach, and continue building a market-leader for companies at the cutting-edge of science and innovation.”

Webster is a private equity firm focused on investment in and development of purpose driven, patient-centric healthcare organizations. Since its founding in 2003, Webster has delivered strong outcomes for investors, portfolio companies, and the communities they serve through its growth-oriented approach.

Clearsight served as the exclusive financial advisor to PQP in its recapitalization by Webster.

“Companies need consulting services they can trust to understand the complexities of their industry and bring thoughtful, actionable strategies to the table,” said Tory Steel and Brendan Curran, Managing Directors at Clearsight Advisors. “PQP has been doing exactly that for over a decade. We look forward to seeing all the new ways that their team will deliver results for companies in the life sciences sector over the coming years.”

The Clearsight deal team included Tory Steel, Brendan Curran, Austin Kuhn, Ashton Neary, and Abby Berry.